Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects.
Marie-Laure BoofAtef HalabiMike UferJasper DingemansePublished in: European journal of clinical pharmacology (2019)
EudraCT: 2017-003725-14; ClinicalTrials.gov: NCT03380455.
Keyphrases